Malaysia Firm Plans To Develop Stem Cell-Based Bone- Marrow Drug
This article was originally published in PharmAsia News
Executive Summary
Stempeutics Research Malaysia said it is ready to launch within the next three years a bone-marrow drug to treat orthopedic and neurology problems